BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fresnais M, Turcan S, Theile D, Ungermann J, Abou Zeed Y, Lindner JR, Breitkopf M, Burhenne J, Haefeli WE, Longuespée R. Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines 2021;10:1. [PMID: 35052681 DOI: 10.3390/biomedicines10010001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Aoki I, Obata T, Higashi T, Bakalova R. Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers 2022;14:485. [DOI: 10.3390/cancers14030485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pastorino F, Brignole C. Editorial of the Special Issue “Targeted Therapies for Cancer”. Biomedicines 2022;10:1114. [DOI: 10.3390/biomedicines10051114] [Reference Citation Analysis]
3 Xin J, Wang S, Wang J, Fu L, Zhang Z, Yao C. A Nucleus-Targeted Nanosystem Integrated with Photodynamic Therapy and Chemotherapy. J Biomed Nanotechnol 2022;18:837-48. [PMID: 35715898 DOI: 10.1166/jbn.2022.3286] [Reference Citation Analysis]